Clinical Trial Update: Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment [Phase 2]

View source ↗

Summary

This Phase 2 trial compares doxycycline with trimethoprim-sulfamethoxazole for MRSA-related skin infections and reports short- and long-term outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Skin and Soft Tissue Infection

Drugs mentioned

• Doxycycline (Doxycycline)
• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Methicillin-resistant Staphylococcus Aureus, Skin Infection | Phase 2 | Status: COMPLETED